vedolizumab (100)(62)

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

QVQLVQSGAE VKKPGASVKV SCKGSGYTFT SYWMHWVRQA PGQRLEWIGE  50

IDPSESNTNY NQKFKGRVTL TVDISASTAY MELSSLRSED TAVYYCARGG 100

YDGWDYAIDY WGQGTLVTVS SASTKGPSVF PLAPSSKSTS GGTAALGCLV 150

KDYFPEPVTV SWNSGALTSG VHTFPAVLQS SGLYSLSSVV TVPSSSLGTQ 200

TYICNVNHKP SNTKVDKKVE PKSCDKTHTC PPCPAPELAG APSVFLFPPK 250

PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY 300

NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP 350

QVYTLPPSRD ELTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP 400

VLDSDGSFFL YSKLTVDKSR WQQGNVFSCS VMHEALHNHY TQKSLSLSPG 450

K                                                      451

Light chain / Chaone lygire / Cadena ligera

DVVMTQSPLS LPVTPGEPAS ISCRSSQSLA KSYGNTYLSW YLQKPGQSPQ  50

LLIYGISNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCLQGTHQP 100

YTFGQGTKVE IKRTVAAPSV FIFPPSDEQL KSGTASVVCL LNNFYPREAK 150

VQWKVDNALQ SGNSQESVTE QDSKDSTYSL SSTLTLSKAD YEKHKVYACE 200

VTHQGLSSPV TKSFNRGEC                                   219

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-96	148-204	265-325	371-429

	22??-96??	148??-204??	265??-325??	371??-429??

Intra-L	23?-93?	139?-199?



	23???-93???	139???-199???



Inter-H-L	224-219?	224??-219???



Inter-H-H	230-230??	233-233??





N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

301, 301??

Molecular formula	C6528H10072N1732O2042S42

Description

immunoglobulin G1-kappa, anti-[Homo sapiens alpha4beta7 integrin
(lymphocyte Peyer?s patch adhesion molecule 1, LPAM-1), humanized
monoclonal antibody;

gamma1 heavy chain (1-451) [humanized VH (Homo sapiens IGHV1-3*01
(84.70%) -(IGHD)-IGHJ4*01) [8.8.14] (1-121) -Homo sapiens IGHG1*01, CH2
L1.2>A, G1>A (122-451)], (224-219?)-disulfide with kappa light chain
(1?-219?) [humanized V-KAPPA (Homo sapiens IGKV2-29*02 (84.00%)
-IGKJ2*01, L124>V) [11.3.9] (1?-112?) -Homo sapiens IGKC*01
(113?-219?)]; (230-230":233-233")-bisdisulfide dimer 

	

WHO 

International Nonproprietary Names Programme	

9093

December 2008

Page 1/1

		

